NATIONAL HEALTHCARE CORP

National Healthcare Corp. insider trades reveal Gifford David R.’s 48% stake reduction, yet continued buying signals confidence in the company’s strong growth and resilient earnings.

Gifford David R. buys 1,021 NHC shares amid insider sales, showing long‑term confidence in National Healthcare Corp’s Alzheimer’s and rehab growth.

Insider sale by LAROCHE RICHARD F JR shows routine liquidity, not a warning; NHCC’s strong growth, Alzheimer’s focus and tele‑health push keep shares poised for future upside.

National HealthCare Corp’s insider sale by SVP Shelly Timothy is a routine portfolio tweak, not a red flag—insider buys and strong earnings keep NHC poised for growth.

National HealthCare Corp insider trades reveal CEO confidence and a strategic nursing‑facility acquisition, highlighting upside potential for investors.

Insider Trail Sandra Y. buys 3,140 NHCC shares at $55.75, 74 % premium over option strike, signaling confidence in NHCC’s long‑term care expansion and Medicare growth prospects.

Insider buying at National HealthCare Corp. signals management confidence – a bullish sign for the company’s growth plans in assisted‑living and Alzheimer’s care, backed by solid earnings and tech adoption.

Insider buying at National HealthCare Corp. signals management confidence, yet investors must weigh modest upside against regulatory risks and a competitive healthcare‑provider landscape.

Insider buys 7,500 shares of National HealthCare Corp at $71.64, below market—signaling strong confidence in NHC’s growth and valuation, and hinting at future upside.

Insider buying at NHC signals long‑term confidence: Vicki Dodson adds 4,000 shares at $94.10, boosting her stake amid strategic growth and a 52‑week high of $184.08.